Bryan Kobel
Chief Executive Officer at TC BIOPHARM (HOLDINGS) PLC
Net worth: 773 $ as of 2023-11-29
Profile
Mr. Bryan Kobel is a Chief Executive Officer at TC BioPharm (North America), Inc., a Chief Executive Officer & Director at TC Biopharm (Holdings) Plc, a CEO-Biopharm North America at TCB Newco Ltd.
and a Chief Executive Officer & Director at TC Biopharm Ltd.
He is on the Board of Directors at TC Biopharm (Holdings) Plc and TC Biopharm Ltd.
Mr. Kobel was previously employed as a Head-Healthcare Investment Banking by HUTN, Inc., a Managing Director by The Alberleen Group LLC, a Head-Capital Markets by R.F.
Lafferty & Co., Inc., and a Managing Director by Laidlaw & Co. (UK) Ltd.
He received his undergraduate degree from Franklin & Marshall College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-05 | 2,101 ( 0.22% ) | 773 $ | 2023-11-29 |
Bryan Kobel active positions
| Companies | Position | Start |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Chief Executive Officer | 2021-05-31 |
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
| TC BioPharm (North America), Inc. | Chief Executive Officer | 2021-05-31 |
TC Biopharm Ltd.
 TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Chief Executive Officer | 2021-05-31 |
Former positions of Bryan Kobel
| Companies | Position | End |
|---|---|---|
The Alberleen Group LLC
 The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | 2020-09-30 |
R.F. Lafferty & Co., Inc.
 R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Corporate Officer/Principal | 2018-05-31 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 2017-03-31 |
| HUTN, INC. | Corporate Officer/Principal | - |
Training of Bryan Kobel
| Franklin & Marshall College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HUTN, INC. | Finance |
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private companies | 6 |
|---|---|
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Finance |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Finance |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
| TC BioPharm (North America), Inc. |
- Stock Market
- Insiders
- Bryan Kobel
